Gerwe, A; Rudolph, B; Bacher, N et al.
Increasing numbers of circulating CD11b+and CD33+MDSC in melanoma patients lead to general reduction of T cell reactivity and correlate with melanoma progressionEXPERIMENTAL DERMATOLOGY. Bd. 21. H. 3. 2012 S. e26-e26
Kryczanowsky, F.; Graulich, E.; Rost, K. et al.
Induction of anergic T cells by CD83highCCR7highHLA-DRhigh as well as CD83lowCCR7negativeHLA-DRlow IL-10-modulated human dendritic cell subpopulationsIMMUNOLOGY. Bd. 137. 2012 S. 422-422
Bork, K; Stanger, C; Wulff, K et al.
Influence of oestrogens on solitary cases of recurrent angioedema: mutations in the factor XII geneALLERGY. Bd. 67. 2012 S. 84-84
Bacher, N; Bopp, T; Becker, C et al.
Interferon-alpha induced reduction of suppressor activity of human CD4+CD25high regulatory T cells is associated with loss of cAMP and altered immuno-phenotypeEXPERIMENTAL DERMATOLOGY. Bd. 21. H. 3. 2012 S. e31-e31
Caballero, Teresa; Farkas, Henriette; Bouillet, Laurence et al.
International consensus and practical guidelines on the gynecologic and obstetric management of female patients with hereditary angioedema caused by C1 inhibitor deficiencyJOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. Bd. 129. H. 2. 2012 S. 308-320
von Stebut, Esther
Langerhans Cells in Anti-Leishmania ResponseEXPERIMENTAL DERMATOLOGY. Bd. 21. H. 10. 2012 S. 809-811
Schermann, A. I.; Lorenz, B.; Tenze, S. et al.
Leishmania major lysate as source for potential immunogenic antigensIMMUNOLOGY. Bd. 137. 2012 S. 480-481
Fischer, M. R.; Lorenz, B.; Radsak, M. et al.
Leishmania major susceptibility is determined by the genetic background of leukocytes, not by stromal cellsEXPERIMENTAL DERMATOLOGY. Bd. 21. H. 3. 2012 S. e37-e37
Schwonberg, K; Brosch, S; van Zandbergen, G et al.
Leishmania major-specific epitopes: identification by in vitro and in vivo analysisEXPERIMENTAL DERMATOLOGY. Bd. 21. H. 3. 2012 S. e37-e38
Mueller-Brenne, Tina; Stanger, Christian; Grabbe, Stephan et al.
Long-lasting complete Remission of metastatic malignant melanoma after reinduction with Ipilimumab, a case ReportJOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. Bd. 10. H. 9. 2012 S. 683-683